Skip to main content

Table 2 Analysis of drug use in Parkinson’s disease patients with dementia

From: Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and acetylcholinesterase inhibitors in Parkinson’s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data

Drug use modality No. of patients (%)
Use of anticholinergics for motor symptoms in Parkinson’s disease 1,268 (19.20)
Use of ACHEIs for dementia 6,460 (92.63)
Concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and ACHEIs
 Concurrent use for ≥ 2 months 847 (9.58)
 Concurrent use for ≥ 1 month 943 (10.66)
 Co-prescribed in the same prescription 701 (7.93)
  1. n = 8,845 Parkinson’s disease patients with dementia
  2. Abbreviations: ACHEI Acetylcholinesterase inhibitor